Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

ClinicalTrials.gov ID: NCT00517829

Public ClinicalTrials.gov record NCT00517829. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Docetaxel Plus Oxaliplatin (DOCOX) With or Without Cetuximab in Patients With Metastatic Gastric and/or Gastroesophageal Junction Adenocarcinoma

Study identification

NCT ID
NCT00517829
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
US Oncology Research
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • Docetaxel Drug
  • cetuximab Drug
  • oxaliplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2007
Primary completion
Mar 31, 2012
Completion
Mar 31, 2012
Last update posted
Nov 27, 2016

2007 – 2012

United States locations

U.S. sites
47
U.S. states
16
U.S. cities
44
Facility City State ZIP Site status
Birmingham Hematology and Oncology Birmingham Alabama 35205
Hematology Oncology Associates Phoenix Arizona 85012
Rocky Mountain Cancer Center - Midtown Denver Colorado 80218
Florida Cancer Institute New Port Richey Florida 34655
Ocala Oncology Center Ocala Florida 34474
Hematology Oncology Associates of Illinois Chicago Illinois 60611
Cancer Care & Hematology Specialists of Chicagoland Niles Illinois 60714
Central Indiana Cancer Centers Indianapolis Indiana 46227
Hope Center Terre Haute Indiana 47802
Kansas City Cancer Centers - Southwest Overland Park Kansas 66210
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404
Missouri Cancer Associates Columbia Missouri 65201
New York Oncology Hematology, P.C. Hudson New York 12534
Interlakes Oncology Hematology, PC Rochester New York 14623
Cancer Centers of North Carolina Raleigh North Carolina 27607
Mahoning Valley Hematology Oncology Associates Boardman Ohio 44514
Greater Dayton Cancer Center Kettering Ohio 45409
Medical Oncology Associates Kingston Pennsylvania 18704
Texas Oncology, P.A. Amarillo Amarillo Texas 79106
Texas Cancer Center Arlington Texas 76014
Texas Oncology Cancer Center Austin Texas 78731
Mamie McFaddin Ward Cancer Center Beaumont Texas 77702
Texas Oncology, P.A. - Bedford Bedford Texas 76022
Texas Cancer Center at Medical City Dallas Texas 75230
Texas Oncology, P.A. Dallas Texas 75231
Methodist Charlton Cancer Ctr. Dallas Texas 75237
Texas Oncology, P.A. Dallas Texas 75246
Texas Cancer Center Denton Texas 76210
El Paso Cancer Treatment Ctr El Paso Texas 79915
Texas Oncology, P.A. Fort Worth Texas 76104
Texas Oncology, P.A. Garland Texas 75042
Lake Vista Cancer Center Lewisville Texas 75067
Longview Cancer Center Longview Texas 75601
Texas Cancer Center of Mesquite Mesquite Texas 75150
Allison Cancer Center Midland Texas 79701
Texas Oncology - Odessa Odessa Texas 79761
Paris Regional Cancer Center Paris Texas 75460
Tyler Cancer Center Tyler Texas 75702
Texas Oncology Cancer and Research Waco Texas 76712
Fairfax Northern VA Hem-Onc PC Arlington Virginia 22205
Virginia Oncology Associates Norfolk Virginia 23502
Onc and Hem Associates of SW VA, Inc. Salem Virginia 24153
Puget Sound Cancer Center - Edmonds Edmonds Washington 98026
Columbia Basin Hematology & Oncology Kennewicke Washington 99336
Puget Sound Cancer Center - Seattle Seattle Washington 98133
Cancer Care Northwest - South Spokane Washington 99202
Northwest Cancer Specialist - Vancouver Vancouver Washington 98684

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00517829, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 27, 2016 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00517829 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →